SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRPs persistent slide and weak, range-bound trading are driving bearish calls and discussion of support levels, with some holders buying the dip. Traders debate whether Ripples adoption and institutional headlines will benefit XRP itself, or whether token supply, escrow releases, and stablecoin use limit token demand.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

The dominant discussion is Compass Pathways anticipated completion of its rolling NDA for COMP360, its investigational psilocybin therapy for treatment-resistant depression, and the prospect of an accelerated FDA review. Bulls see the regulatory milestone as a catalyst, while others are frustrated by the share-price decline and cautious management commentary and question the timing.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs recent approvals of GENGLYCOS and FAYUVI, alongside plans to monetize the associated priority review vouchers, are driving discussion about new revenue opportunities and non-dilutive funding. Bulls see stronger prospects for profitability and a valuation rebound, while skeptics point to the stocks muted response, cash burn, and uncertainty around commercial uptake; short-squeeze talk remains speculation.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Traders are focused on the upcoming CTX310 Phase 1b data presentation at the AHA meeting, viewing results in severe hypertriglyceridemia as a key test of CRISPR Therapeutics in vivo gene-editing approach. Some are positioning ahead of the readout, while others remain skeptical after the stocks prolonged range-bound trading and debate whether clinical progress will translate into a sustained move.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

Interactive Brokers Q3 results are driving discussion, with traders weighing growth in client accounts and net interest income against softer trading activity and a muted share-price reaction. Some see the businesss profitability and higher dividend as supportive, while others cite competition and valuation concerns.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuitys ESMO updates on gedatolisib are driving discussion, with traders highlighting encouraging breast-cancer Phase 3 results and early prostate-cancer activity. Some question the weak share performance despite the data, while others stress that the prostate findings are from small, uncontrolled groups and that commercial uptake remains to be demonstrated.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

INFQ is drawing attention amid a sharp selloff across quantum and small-cap tech stocks, with traders debating whether oversold conditions signal a buying opportunity or further downside. A Google quantum-computing breakthrough has added speculative optimism about potential spillover to Infleqtions neutral-atom technology, but a direct benefit is not established.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines earnings outlook, which points to losses as elevated jet-fuel costs squeeze margins despite record revenue, is driving attention. Bearish traders worry about fuel costs and debt, while some bulls see strong demand and the selloff as a potential bounce opportunity.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad-market concerns about elevated valuations, AI spending, rising rates, oil prices and debt, with bearish traders warning of a correction. Others favor the ETF as a diversified, long-term holding and discuss steady investing through volatility, leaving the conversation split between near-term caution and buy-and-hold confidence.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

BETRs sharp rebound and announced share-repurchase program, alongside weekly turnaround updates, have traders focused on a possible short squeeze amid reports of a heavily shorted, limited float. Some question whether a squeeze is actually underway, pointing to pullbacks and fading volume.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Target is drawing attention after a sharp pullback gave back the prior sessions gains, with traders debating whether buyers will defend technical support and positioning ahead of the next earnings report. Some see the dip as an opportunity based on the companys earlier earnings beat and turnaround, while others remain bearish on the stocks weakness.

Target Corporation (TGT) Is a Trending Stock: Facts to Know Before Betting on It

Target (TGT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Target Completes SoHo Store Transformation, Bringing Style and Design to Every Target Run

Target Completes SoHo Store Transformation, Bringing Style and Design to Every Target Run Target Completes SoHo Store Transformation, Bringing Style and Design to Every Target RunPR NewswireMINNEAPOLIS, Oct 22, 2026 Newly transformed lower level brings the retailer's design-led vision to home...

Target Brings More Value and Delight to Thanksgiving with a $30 Meal for Six and Fresh Takes on Holiday Favorites

Target Brings More Value and Delight to Thanksgiving with a $30 Meal for Six and Fresh Takes on Holiday Favorites Target Brings More Value and Delight to Thanksgiving with a $30 Meal for Six and Fresh Takes on Holiday FavoritesPR NewswireMINNEAPOLIS, Oct. 22, 2026 Nearly 60 new food and beverage...

Target (TGT) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Target (TGT) closed at $152.38, marking a -1.05% move from the previous day.

TGT or TJX: Which Is the Better Value Stock Right Now?

TGT vs. TJX: Which Stock Is the Better Value Option?

Target Makes it Easier for Guests to Discover Stylish Holiday Gifts They Can't Wait to Give

Target Makes it Easier for Guests to Discover Stylish Holiday Gifts They Can't Wait to Give Target Makes it Easier for Guests to Discover Stylish Holiday Gifts They Can't Wait to GivePR NewswireMINNEAPOLIS, Oct 21, 2026 Target is offering more than 8,000 new gifts, with more than half exclusive to...

Can Abercrombie's Target Partnership Fuel Hollister's Growth?

ANF's Hollister expands into more than 1,500 Target stores, tapping new product categories and customers. Can this partnership drive sustained growth?

Walmart, Target and Costco Win Over Digital Shoppers With Speed

Walmart, Target and Costco drive digital sales growth through faster delivery, AI-powered shopping, marketplace expansion and strategic partnerships.

Should Value Investors Buy Target (TGT) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Buy 5 Top-Ranked High-Flying Non-Tech, Non-AI Stocks for a Strong Q4

ROST, ROKU, IBKR, TGT and NUE are non-tech, non-AI stocks delivering over 25% returns, with strong earnings growth, improving estimates and business expansion.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Stocktwits Wall Street Wrap: Analysts Turn Bullish On Sweetgreen, Target And Airbnb – Liquidia And FICO Face Downgrades

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Wells Fargo upgraded Sweetgreen and raised its price target, citing easing Cyclospora concerns and improving traffic.&nbsp;</li><li>HSBC upgraded Target, while KeyBanc raised Airbnb on durable growth and hotel expansion potential.&nbsp;</li><li>Wells Fargo and BTIG downgraded Liquidia after a court found Yutrepia infringed United Therapeutics patents.&nbsp;</li></ul><p>Six stocks are drawing fresh attention after Wall Street analysts changed their views on everything from restaurant traffic and retail demand to travel growth, patent risks and credit-score competition. Sweetgreen Inc. (SG), Target Corp. (<a class="mention" data-mention="$TGT" data-symbol-id="TGT" href="https://stocktwits.com/symbol/TGT" target="_blank">TGT</a>) and Airbnb Inc. (ABNB) received upgrades, while Liquidia Corp. (LQDA), Sea Ltd. (SE) and Fair Isaac Corp. (FICO) faced downgrades or sharply lower price targets.&nbsp;</p><h2 class="st-heading-2">Cyclospora Concerns Ease As Sweetgreen Traffic Shows Signs Of Recovery&nbsp;</h2><p>Wells Fargo upgraded Sweetgreen to ‘Overweight’ from ‘Equal Weight’ and lifted its price target to $11 from $6 after discussions with management. The firm said concerns tied to the Cyclospora outbreak appear to be easing, while Sweetgreen’s operational changes are starting to show results.</p><p>Wells Fargo said Sweetgreen was not responsible for the Cyclospora incident, but the episode hurt demand across the salad category. The company now sees customer traffic improving, while the analyst expects management could rely more on pricing to help absorb higher costs.</p><p>Sweetgreen shares have fallen 80% from their November 2024 peak, but improving traffic, new wraps and the end of the Cyclospora outbreak could support a recovery.&nbsp;<a href="https://stocktwits.com/symbol/SG">Sweetgreen stock</a> has gained over 5% so far this week and is on track for a fourth week of gains.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261002_054252505_d7d79db7eb.png" alt="koyfin_20261002_054252505.png" width="2400" height="1240"></figure><h2 class="st-heading-2">HSBC Turns Bullish On Target, Airbnb Could Grow Beyond Core Rentals&nbsp;</h2><p>HSBC upgraded Target to ‘Buy’ from ‘Hold’ and raised its price target to $190 from $125. Analyst Joe Thomas pointed to the retailer’s Q2 performance as evidence that customer visits are improving and that its turnaround efforts are gaining traction. HSBC also sees room for earnings to surpass current expectations.</p><p>KeyBanc&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/abnb-stock-eyes-snapping-4-week-losing-streak-key-banc-upgrades-airbnb-on-hotel-growth-valuation/cZDSvbKRB0m">upgraded</a> Airbnb to ‘Overweight’ from ‘Sector Weight’ and set a $191 price target. Analyst Sergio Segura said Airbnb’s main business continues to grow steadily, while hotel bookings could become a new source of growth.&nbsp;</p><p>While&nbsp;<a href="https://stocktwits.com/symbol/TGT">Target stock</a> was down 0.4% this week,&nbsp;<a href="https://stocktwits.com/symbol/ABNB">Airbnb stock</a> has gained nearly 2%.&nbsp;</p><h2 class="st-heading-2">Yutrepia Patent Dispute Creates Fresh Uncertainty For Liquidia&nbsp;</h2><p>Wells Fargo downgraded Liquidia to ‘Equal Weight’ from ‘Overweight’ and slashed its target to $30 from $108. The firm cited greater uncertainty for the company after a court&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lqda-stock-eyes-worst-day-ever-after-judge-upholds-two-uthr-patent-claims/cZMFSOCRBL0">ruling</a> and expressed limited confidence that Liquidia will prevail on appeal.</p><p>A Delaware judge ruled that Liquidia’s Yutrepia infringes two United Therapeutics (UTHR) patent claims. Both offer inhaled treprostinil treatments for pulmonary arterial hypertension (PAH) and PH-ILD . United sells Tyvaso products, while Liquidia’s Yutrepia, approved in 2025, is a dry-powder competitor. The disputed patent covers using inhaled treprostinil to improve exercise ability in PH-ILD patients.&nbsp;</p><p>BTIG separately lowered Liquidia to ‘Neutral’ from ‘Buy’, citing that the judgment could potentially halt Yutrepia across indications until the pulmonary hypertension indication is removed from its label.&nbsp;<a href="https://stocktwits.com/symbol/LQDA">Liquidia stock&nbsp;</a>is on track for its worst week ever with a 59% crash.</p><h2 class="st-heading-2">DBS Bank Cuts Sea Rating While BofA Flags Risks For FICO&nbsp;</h2><p>DBS Bank downgraded Sea to ‘Hold’ from ‘Buy’ and cut its price target to $105 from $148. The firm said Shopee is gaining strength but higher spending is hurting margins. It also faces competition from PDD’s cross-border business and Shopee’s push into quick commerce.&nbsp;</p><p>BofA moved Fair Isaac to ‘Neutral’ from ‘Buy’ and cut its price target to $700 from $1,400 after the Federal Housing Finance Agency placed VantageScore 4.0 and Classic FICO on the same loan-pricing adjustment framework. BofA said the change could encourage lenders to consider VantageScore more widely, creating additional risks for FICO’s pricing, volume and market share.</p><p><a href="https://stocktwits.com/symbol/SE">Sea stock</a> is heading for a fifth straight week of losses, with a 4.3% decline, while&nbsp;<a href="https://stocktwits.com/symbol/FICO">Fair Isaac stock</a> is down 23% and is on track for its worst month since March.&nbsp;</p><p>So far this year, SG, <a class="mention" data-mention="$TGT" data-symbol-id="TGT" href="https://stocktwits.com/symbol/TGT" target="_blank">TGT</a> and ABNB stocks gained between 18% and 60%, while LQDA, SE and FICO stocks crashed between 18% and 60%&nbsp;</p><p>Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-heads-for-a-weekly-loss-morningstar-says-nike-s-fresh-cost-cuts-signal-a-longer-road-to-recovery/cZDj37eRBKb">NKE Stock Heads For A Weekly Loss: Morningstar Says Nike's Fresh Cost Cuts Signal A Longer Road To Recovery</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Shoppers walk past the entrance to a Target store in Washington, DC.

Six stocks are drawing fresh attention after Wall Street analysts changed their views on everything from restaurant traffic and retail demand to travel growth, patent risks and credit-score competition. Sweetgreen Inc. (SG), Target Corp. (TGT) and Airbnb 

The changes reflect new views on restaurant demand, retail traffic, travel growth, drug risks and competition in financial data.


Airbnb Inc

Fair, Isaac Corp.

Liquidia Corp

Sea Ltd - ADR

Sweetgreen Inc - Ordinary Shares - Class A

Yes, buying

No, staying away

Just holding what I have

Watching from the sidelines

Walmart ($WMT) is pulling back despite beating Q2 earnings estimates and raising full-year EPS guidance, as investors react to disappointing comparable sales growth and cautious Q3 commentary. Are you buying $WMT on the dip? Vote and explain your reasoning in the comments.

Walmart ($WMT) stock is down despite a Q2 earnings beat and raised full-year profit forecast. Are you buying the dip?

Stocktwits

Walmart Inc

) stock is down despite a Q2 earnings beat and raised full-year profit forecast. Are you buying the dip?

Feed

News

Sentiment

Earnings

Fundamentals

Info

TGT News